X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CARDIOVASCULAR THERAPY AND PREVENTION

期刊標題檢索 CARDIOVASC THER 最新評論: The selection of keywords should cover the key industries of the manus... (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CARDIOVASCULAR THERAPY AND PREVENTION]您好,您是該頁面的第 7792 位訪客。

期刊簡介
期刊名稱CARDIOVASCULAR THERAPY AND PREVENTION CARDIOVASCULAR THERAPY AND PREVENTION

(According to the latest JCR data, this journal is not indexed in the JCR.)
LetPub Score
3.6
50 ratings
Rate

Reputation
4.2

Influence
2.3

Speed
7.0

期刊簡稱CARDIOVASC THER PREV
ISSN1728-8800
h-index11
CiteScore
CiteScoreSJRSNIPCiteScore Rank
1.700.2120.572
Subject fieldQuartilesRankPercentile
Category: Social Sciences
Subcategory: Education
Q3855 / 1543
Category: Social Sciences
Subcategory: Cardiology and Cardiovascular Medicine
Q3259 / 387

自引率 (2023-2024)N.A.自引率趨勢
掲載範囲
The most important objectives of the journal are: the generalization of scientific and practical achievements in the field of cardiology, increasing scientific and practical skills of cardiologists.

The scientific concept of publication does the publication of modern achievements in the field of epidemiology, prevention and treatment of cardiovascular diseases, the results of research, national and international clinical trials.

For publication in the journal are invited both domestic and foreign scientists and clinicians working in the field of cardiology, as well as doctors of other specialties.

The magazine covers various issues in cardiology and related specialties. Each issue is prepared by Executive editor of the issue, a respected specialist in the field of epidemiology, prevention and treatment of cardiovascular diseases.

The main focus of the publication — scientific articles on original research, the pharmacotherapy of cardiovascular disease, new diagnostic methods.

All members of the group of authors should meet all four criteria of authorship set forth in the ICMJE recommendations: 1) concept and design development or data analysis and interpretation, and 2) manuscript justification or verification of critical intellectual content, and 3) final approval for publication of the manuscript, and 4) consent to be responsible for all aspects of the work, and assume that issues relating to the thoroughness and diligent execution of any part of the study submitted are duly investigated and resolved.

Great importance the editors attached to the preparation of scientific papers by groups of authors at a high level, literacy, authors, and their ownership information, availability of research results not only to colleagues in Russia, but also abroad.
官方網站http://roscardio.ru/en/cardiovascular-therapy-and-prevention.html
在線稿件提交http://icmje.org/news-and-editorials/sharing_clinical_trial_data_comments_feed.html
開放訪問No
出版商Vserossiiskoe Obshchestvo Kardiologov
主題領域Medicine
出版國/地區
發行頻率隔月刊行
創刊年0
每年文章數75每年文章數趨勢
黃金OA百分比0.00%
Web of Science 四分位
2023-2024
WOS Quartile: Q0

N/A
索引 (SCI or SCIE)
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1728-8800%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【CARDIOVASCULAR THERAPY AND PREVENTION】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    JAMA CardiologyH-index: 30

    CiteScore: 45.80
    Circulation-Cardiovascular Quality and OutcomesH-index: 75

    CiteScore: 9.80
    European Heart Journal-Cardiovascular PharmacotherapyH-index: 0

    CiteScore: 10.10
    Stroke and Vascular NeurologyH-index: 0

    CiteScore: 11.20
    Cardiac Failure ReviewH-index: 0

    CiteScore: 5.60
    ESC Heart FailureH-index: 0

    CiteScore: 7.00
    Global HeartH-index: 0

    CiteScore: 5.70
    Frontiers in Cardiovascular MedicineH-index: 0

    CiteScore: 3.80
    CJC OpenH-index: 0

    CiteScore: 3.30
    BLOOD PRESSUREH-index: 0

    CiteScore: 3.20
    學科內最受檢索的期刊 頁面查看次數
    Frontiers in Cardiovascular Medicine118514
    JAMA Cardiology27294
    ESC Heart Failure25132
    Stroke and Vascular Neurology19700
    Cardiology Research and Practice18603
    Cardiovascular Diagnosis and Therapy14654
    Circulation-Cardiovascular Quality and Outcomes13090
    Global Heart12798
    Netherlands Heart Journal12087
    European Heart Journal-Cardiovascular Pharmacotherapy11389
  •  

    CARDIOVASCULAR THERAPY AND PREVENTION CARDIOVASCULAR THERAPY AND PREVENTION
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [CARDIOVASCULAR THERAPY AND PREVENTION] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 15:57:26 評論於
The selection of keywords should cover the key industries of the manuscript as much as possible, for example, choose 4 keywords, the first 2 keywords can define the scientific research industry or the other half of scientific research, and the latter 2 keywords can choose research methods, research methods, as much as possible. Let readers find the author's manuscript very easily from each perspective
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 13:23:27 評論於
According to the requirements of the journal, but not all journals have these requirements
(0) 讚! | 维尔娜菲茨杰拉德

作者: 上清雨真


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 17:03:15 評論於
Is it necessary to have a Graphical Abstract in your submission?
(0) 讚! | 上清雨真

作者: 八坂篷蔚


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 16:04:49 評論於
How to Choose the First Two Keywords?
(0) 讚! | 八坂篷蔚

作者: 凌霄高洁


領域:
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-06-07 21:51:46 評論於
Lost SCI in 2013
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [CARDIOVASCULAR THERAPY AND PREVENTION] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*